Ali Nowrouzi
Impact in
- Genetics top 2%
- Virus-based gene therapy research
Papers in
- Genetics 17
- Virus-based gene therapy research 16
- Animal Genetics and Reproduction 3
-
- CRISPR and Genetic Engineering 12
- RNA Interference and Gene Delivery 6
- Pluripotent Stem Cells Research 3
- Co-authors
- Christof V. Kalle (14 shared papers)Manfred Schmidt (17 shared papers)Hanno Glimm (8 shared papers)Christine Kaeppel (4 shared papers)Anne I.J. Arens (3 shared papers)Claudia R. Ball (3 shared papers)Richard O. Snyder (2 shared papers)Magalie Penaud‐Budloo (2 shared papers)
- Journals
- Molecular Therapy (5 papers)Nature Medicine (2 papers)Cell Reports (2 papers)Nature Communications (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Ali Nowrouzi
30 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 84
- Genetics 1.2k
- Business and International Management 64
- Oncology 644
- Molecular Biology 1.7k
- Virology 91
Countries citing papers authored by Ali Nowrouzi
This map shows the geographic impact of Ali Nowrouzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Nowrouzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Nowrouzi more than expected).
Fields of papers citing papers by Ali Nowrouzi
This network shows the impact of papers produced by Ali Nowrouzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Nowrouzi. The network helps show where Ali Nowrouzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Nowrouzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 438 | |
| 2 | 2011 | 437 | |
| 3 | 2011 | 253 | |
| 4 | 2008 | 240 | |
| 5 | 2009 | 160 | |
| 6 | 2013 | 152 | |
| 7 | 2015 | 96 | |
| 8 | 2012 | 91 | |
| 9 | 2012 | 85 | |
| 10 | 2006 | 81 | |
| 11 | 2021 | 70 | |
| 12 | 2011 | 58 | |
| 13 | 2018 | 47 | |
| 14 | 2010 | 38 | |
| 15 | 2011 | 36 | |
| 16 | 2018 | 30 | |
| 17 | 2011 | 24 | |
| 18 | 2017 | 24 | |
| 19 | 2009 | 23 | |
| 20 | 2013 | 20 |
About Ali Nowrouzi
Ali Nowrouzi is a scholar working on Genetics, Molecular Biology, Oncology, Virology and Cancer Research, having authored 30 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), CRISPR and Genetic Engineering (12 papers), RNA Interference and Gene Delivery (6 papers), CAR-T cell therapy research (4 papers), Animal Genetics and Reproduction (3 papers), Pluripotent Stem Cells Research (3 papers), HIV Research and Treatment (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Genetics (1.2k citations), Business and International Management (64 citations), Oncology (644 citations), Molecular Biology (1.7k citations) and Virology (91 citations). Ali Nowrouzi has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christof V. Kalle, Manfred Schmidt, Hanno Glimm, Christine Kaeppel, Anne I.J. Arens, Claudia R. Ball, Richard O. Snyder, Magalie Penaud‐Budloo, Caroline Le Guiner and Philippe Moullier. Their work appears in journals such as Molecular Therapy, Nature Medicine, Cell Reports, Nature Communications and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.